# Useful care changes something you can feel or do *Evidence and Tradeoffs — Non-Surgical Knee Treatment Peoria* > A clear look at non-surgical knee treatment Peoria choices, what improvement means and how to judge soreness during daily life. ## Knee soreness can change before care even starts Your knee may feel better one day and worse the next. Activity, weather, and rest can change the ache during a week. One good morning doesn't prove that a treatment worked. A regular daily task gives you a steadier way to judge. Pick stairs, a grocery trip, or another task you often do. Note how long you walk and how the knee feels afterward. Check the same task again on a similar day. This short record is easier to trust than memory alone. ## Useful care has a result you can check Each type of care needs a clear result before you begin. Exercise may help strength, balance, or comfortable walking. A brace may support your knee during errands. If you can't name the result, ask before spending money. ## Concentrated PRP starts with blood drawn from your arm The name PRP comes from platelet-rich plasma, which is made from your blood. A clinic worker spins a blood sample so the platelets separate. A medical provider puts that prepared portion into the knee with a shot. QC Kinetix calls this regenerative treatment because it uses part of your body. The exam comes before any knee shot is offered. Ask which finding gives the provider a reason to offer it. You'll need the full price and the number of return visits. You can also ask what the care cannot do. ## Set the check date before treatment begins Ask the provider when to repeat your chosen daily task. Write that date with your walking and soreness notes. If the ache gets worse before then, call sooner. At follow-up, say plainly whether stairs, sleep, or walking changed. ## Sources 1. In 156 patients with knee osteoarthritis randomised in the US Military Health System, physical therapy produced a mean WOMAC total score of 37.0 at one year versus 55.8 for a single intra-articular glucocorticoid injection (mean between-group difference 18.8 points favouring physical therapy, 95% CI 5.0 to 32.6, on a 0-240 scale where higher is worse). Secondary outcomes moved in the same direction. Deyle GD, Allen CS, Allison SC, et al. — [Physical Therapy versus Glucocorticoid Injection for Osteoarthritis of the Knee.](https://pubmed.ncbi.nlm.nih.gov/32268027/). *New England Journal of Medicine*, 2020. DOI: 10.1056/NEJMoa1905877. 2. In a 2-year double-blind randomised trial in 140 patients with symptomatic knee OA (Kellgren-Lawrence grade 2 or 3) and ultrasonic synovitis, intra-articular triamcinolone 40mg every 12 weeks produced significantly greater cartilage volume loss than saline (index-compartment cartilage thickness change -0.21mm vs -0.10mm; between-group difference -0.11mm, 95% CI -0.20 to -0.03) with no significant difference in pain. McAlindon TE, LaValley MP, Harvey WF, et al. — [Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients With Knee Osteoarthritis: A Randomized Clinical Trial.](https://pubmed.ncbi.nlm.nih.gov/28510679/). *JAMA*, 2017. DOI: 10.1001/jama.2017.5283. 3. A systematic review and meta-analysis of 169 randomised trials (21,163 participants) of viscosupplementation for knee OA found clear evidence of small-study effects and publication bias. The prespecified main analysis, restricted to 24 large placebo-controlled trials with at least 100 participants per group (8,997 randomised), found a pain reduction of SMD -0.08 (95% CI -0.15 to -0.02) - the confidence interval excluding the prespecified minimal clinically important difference of -0.37. Pereira TV, Jüni P, Saadat P, et al. — [Viscosupplementation for knee osteoarthritis: systematic review and meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/36333100/). *BMJ*, 2022. DOI: 10.1136/bmj-2022-069722. 4. The RESTORE trial randomised 288 community-based participants aged 50+ with symptomatic medial knee OA (Kellgren-Lawrence grade 2 or 3) to three weekly intra-articular injections of leukocyte-poor PRP or saline placebo, with participants, injectors and assessors all blinded. 93% completed the 12-month follow-up. PRP did not produce a clinically meaningful improvement in knee pain over placebo, and did not slow medial tibial cartilage volume loss on MRI. Bennell KL, Paterson KL, Metcalf BR, et al. — [Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.](https://pubmed.ncbi.nlm.nih.gov/34812863/). *JAMA*, 2021. DOI: 10.1001/jama.2021.19415. 5. A meta-analysis of 16 randomised trials (807 participants) of intra-articular mesenchymal stem cells for chronic knee pain from osteoarthritis found that at 3-6 months MSC therapy probably produces little to no difference in pain (WMD -0.74cm on a 10cm VAS, 95% CI -1.16 to -0.33, against a minimally important difference of 1.5cm) or physical function, both moderate certainty; at 12 months, probably little to no difference in pain. MSC therapy may increase the risk of any adverse event (RR 2.67, 95% CI 1.19 to 5.99) and of knee pain and swelling (RR 1.58, 95% CI 1.04 to 2.38). Sadeghirad B, Rehman Y, Khosravirad A, et al. — [Mesenchymal stem cells for chronic knee pain secondary to osteoarthritis: A systematic review and meta-analysis of randomized trials.](https://pubmed.ncbi.nlm.nih.gov/38777213/). *Osteoarthritis and Cartilage*, 2024. DOI: 10.1016/j.joca.2024.04.021. 6. FDA states directly that regenerative medicine therapies - including stem cells, stromal vascular fraction, umbilical cord blood, amniotic fluid, Wharton's jelly, ortho-biologics and exosomes - have NOT been approved for the treatment of any orthopedic condition, naming osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain and shoulder pain. FDA further states that being charged for these products, or being offered them outside an FDA-overseen clinical trial, means a patient is likely being deceived and offered a product illegally, and that a product's presence on clinicaltrials.gov or a firm's FDA registration does not mean the product is legally marketed. Reported harms include blindness, tumor formation, neurological events and life-threatening bacterial infections. US Food and Drug Administration, Center for Biologics Evaluation and Research — [Important Patient and Consumer Information About Regenerative Medicine Therapies](https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/important-patient-and-consumer-information-about-regenerative-medicine-therapies). *FDA.gov*, 2021. ## A consultation can clarify the next step At the Peoria clinic, QC Kinetix offers regenerative treatments, or care prepared from parts of your blood. Concentrated PRP uses blood that staff draw and spin to gather platelets. A medical provider then gives the prepared liquid as a knee shot. The consultation costs you nothing, so ask about the shot, follow-up, and price. Book a free consultation: --- Knee soreness, home care and visits without surgery. A plain guide to non-surgical knee treatment Peoria readers can use for soreness, things to do at home, clinic visits and surgery choices. Plain help with knee soreness, home care, clinic choices and surgery timing in Peoria. This site is operated by the owners of the QC Kinetix Phoenix-area clinics, including the Peoria location recommended here, and the business can benefit when readers book a consultation. Copyright 2026 The Peoria Knee Ledger. General education only; diagnosis, benefits verification and treatment decisions require the appropriate clinician or health plan.